Aberdeen Group’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-243,044	Closed	-$5.44M	–	951
2024 Q2	$5.44M	Buy	243,044 +88,775	+58%	+$1.99M	0.01%	606
2024 Q1	$4.24M	Hold	154,269	–	–	0.01%	698
2023 Q4	$4.7M	Buy	+154,269	New	+$4.7M	0.01%	677